West Pharmaceutical Services Inc(WST) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 44.26 | EPS (ttm) | 7.82 | Insider Own | 0.75% | Shs Outstand | 70.4M | Perf Week | 1.02% |
| Market Cap | 24.37B | Forward P/E | 34.65 | EPS next Y | 11.39% | Insider Trans | -2.2% | Shs Float | 69.8M | Perf Month | -1.72% |
| Enterprise Value | 24.25B | PEG | 2.17 | EPS next Q | 2.19 | Inst Own | 102.42% | Short Float | 3.14% | Perf Quarter | 4.81% |
| Income | 0.56B | P/S | 7.32 | EPS this Y | 23.05% | Inst Trans | -2.07% | Short Ratio | 3.2 | Perf Half Y | 49.82% |
| Sales | 3.33B | P/B | 8.15 | EPS next 5Y | 15.98% | ROA | 14.07% | Short Interest | 2.20M | Perf YTD | 25.84% |
| Book/sh | 42.47 | P/C | 55.91 | EPS past 3/5Y | -4.22% 8.26% | ROE | 19.09% | 52W High | -10.3% ($386.00) | Perf Year | 31.28% |
| Cash/sh | 6.19 | P/FCF | 55.77 | Sales past 3/5Y | 2.14% 7.45% | ROIC | 17.2% | 52W Low | 54.68% ($223.83) | Perf 3Y | -12.82% |
| Dividend Est. | $0.83 (0.24%) | EV/EBITDA | 26.57 | EPS Y/Y TTM | 17.07% | Gross Margin | 36.82% | Volatility(W/M) | 2.12% 2.06% | Perf 5Y | -24.57% |
| Dividend TTM | 0.88 | EV/Sales | 7.29 | Sales Y/Y TTM | 12.42% | Oper. Margin | 21.97% | ATR (14) | 7.83 | Perf 10Y | 331.76% |
| Dividend Ex-Date | 2026/7/29 | Quick Ratio | 2.12 | EPS Q/Q | 18.81% | Profit Margin | 16.98% | RSI (14) | 51.83 | Recom | 1.4 |
| Dividend Gr. 3/5Y | 5.14% 5.44% | Current Ratio | 2.82 | Sales Q/Q | 13.86% | SMA20 | 0.24% ($345.4) | Beta | 1.13 | Target Price | $409.73 |
| Payout | 12.66% | Debt/Eq | 0.11 | Earnings | 2026/7/23 | SMA50 | -0.75% ($348.85) | Rel Volume | 0.79 | Prev Close | $344.25 |
| Employees | 10800 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | 13.86% 3.85% | SMA200 | 17.24% ($295.32) | Avg Volume(3M) | 0.69M | Price | $346.23 |
| IPO | 1980/3/17 | Option/Short | Yes/Yes | Trades | 11631 | Volume | 537,961 | Change | 0.58% |
Company
WST is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🧪 West Pharmaceutical Services (WST) is a global leader in the packaging and delivery systems market for injectable pharmaceuticals. The company manufactures and supplies packaging solutions—such as high-performance elastomer stoppers, vial seals, and self-injection systems—that help ensure the stable storage and administration of high-value medications.
Over the past 1 year, on the higher side
10% below its 1-year high.
WST makes money exceptionally well
21.97% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +23.1% this year.
Tap to view numbers
The price looks about right
Trading at 44.3 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -12.8% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.24% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 102.4%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 in the industry
Based on market cap of $24B.
FAQ
What kind of company is WST?
WST belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of WST?
The market cap of WST is approximately $24.4B, ranking 532 within its sector.
Does WST pay dividends?
WST has a dividend yield of approximately 0.24%, with an annual dividend of $0.83.
What is the P/E ratio of WST?
WST has a P/E ratio of approximately 44.3x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for WST?
WST has recorded a 52-week high of $386.00 and a low of $223.83.